losartan / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 233 Diseases   125 Trials   125 Trials   3075 News 
160 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
losartan / Generic mfg.
ACTRN12617001533381p: Combination low dose blood pressure lowering treatment for patients with untreated hypertension

Not yet recruiting
4
12
 
George Medicines, George Medicines (The George Institute)
Hypertension
 
 
ACTRN12617001533381: Combination low dose blood pressure lowering treatment for patients with untreated hypertension

Not yet recruiting
4
12
 
George Medicines, George Medicines (The George Institute)
Hypertension
 
 
ACTRN12619000861156p: A comparison of drug metabolism in healthy volunteers and patients with severe chronic obstructive lung disease (COPD)

Not yet recruiting
4
24
 
Dr Richard McNeill, Canterbury Medical Research Foundation
Chronic obstructive Pulmonary Disease (COPD); Drug metabolism
 
 
ACTRN12619000861156: A comparison of drug metabolism in healthy volunteers and patients with severe chronic obstructive lung disease (COPD)

Not yet recruiting
4
24
 
Dr Richard McNeill, Canterbury Medical Research Foundation
Chronic obstructive Pulmonary Disease (COPD), Drug metabolism
 
 
2020-003647-28`ACTRN12620001373965: Blood pressure lowering drug concentration differences in the blood of patients with hypertension: Old vs. Young 2

Ongoing
4
80
Europe
Film-coated tablet, Losartan potassium, Perindopril Arginine
Monash Medical Centre , Monash University Health Practitioner Research Fellowship
The pharmacokinetics of oral creatine monohydrate (CrM) dosing in pregnancy, Metabolism of nutraceutical supplement (creatine monohydrate) in pregnancy
 
 
ChiCTR-TRC-09000462: A randomized, controlled trial to evaluate the safety and efficacy of losartan in obvious proteinuria patients with lower-normal blood pressure

Completed
4
30
 
None ;Losartan 25-50mmHg
Renji Hospital of Shanghai Jiaotong University; Level of the institution:, self-funded
CKD with obvious proteinuria
 
 
ChiCTR-TRC-09000426: Randomized controlled trial of losartan\propranolol in treating portal hypertension

Completed
4
90
 
Oral losartan by 25mg/d of the initial dose, three days latter alternate to 50mg/d ;Oral propranolol by 20mg/d of initial dose; then, progressively increase 10mg/d, max dose 120mg/d or rest heart rate reduced to the 75% of fundamental rate, or no less than 55/min ;Placebo
Department 1 of Infectious Diseases, 302 Hospital of P.L.A; Level of the institution:, self-finance
portal hypertension
 
 
ChiCTR-TRC-06000004: ACEi/ARB alone versus ACEi/ARB plus Steroids in the treatment of primary IgA nephropathy, a randomized multicenter controlled trial

Completed
4
156
 
treated with ACEI/ARB( ARB therapy is subjected to patients with cough after use of ACEI) Inhibace (cilazapril): start at 1.25mg/day, increase the dose by 1.25mg/day/week to 2.5-5mg/day Cozaar (losartan): 25~50mg/day, increased to 50~100mg/day Last for one year; Oral prednisone for 6 mos 0.8mg/kg/day x 8 wks Tapered 0.2mg/kg/day/mo in combination with ACEI/ARB
The First Hospital, Peking University; Capital Research Funding for the Development of Medicine, Capital Research Funding for the Development of Medicine
primary IgA nephropathy
 
 
ChiCTR-TRC-11001653: The research about decompression cure IFG and Hypertension

Completed
4
600
 
Levamlodipine Besylate ;Losartan
Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing; Endocrinology department, The Third Military Medical College, Southwest Hospital Chongqing, hospital administration funds
IFG and Hypertension
 
 
ChiCTR-TRC-11001282: Triptolide Retards Autosomal Dominant Polycystic Kidney Disease with Proteinuria

Completed
4
60
 
Glucosidorum Tripterygll Totorum+losartan potassium ;Placebo + losartan potassium
Shanghai Changzheng Hospital; Science and Technology Commission of Shanghai, Shanghai Key Discipline Project.(No:B902) Shanghai Science and Technology Commission Major Research Project.(No:08dz1900601)
Autosomal dominant polycystic kidney disease
 
 
ChiCTR-TRC-10000923: Therapeutic effect and safety of Huangkui Capsule for chronic kidney disease: a multi-center, randomized, open label study

Completed
4
420
 
Huangkui Capsule, 2.5g, tid,for 24 weeks ;Losartan, 50mg qd, for 24 weeks ;Huangkui Capsule, 2.5g, tid+ losartan 50mg qd, for 24 weeks
Chinese General Hospital of PLA; SZYY Group Pharmaceutical, SZYY Group Pharmaceutical Limited
chronic kidney disease
 
 
ChiCTR-TRC-13003612: A Clinical Study of the Efficacy and Safety of Shenyankangfu Tablets in the Treatment of Primary Glomerulonephritis and Diabetic Kidney Disease

Suspended
4
720
 
shenyankangfu tablets + Losartan potassium tablets mimetic agent×2 ;shenyankangfu tablets mimetic agent +losartan potassium tablets 50mg +losartan potassium tablets mimetic agent ;shenyankangfu tablets mimetic agent +losartan potassium tablets 50mg×2 ;shenyankangfu tablets + Losartan potassium tablets 50mg+ losartan potassium tablets mimetic agent ;shenyankangfu tablets +losartan potassium tablets 50mg×2
Chinese PLA General Hospital; Tianjin TongRenTang Group Co., Ltd., Enterprise Support
Primary Glomerulonephritis and Diabetic Kidney Disease
 
 
2004-002020-17: ESTRATEGIAS PARA EL TRATAMIENTO DE LA HIPERTENSIÓN ARTERIAL. EVALUACIÓN DE UNA TERAPIA COMBINADA A DOSIS FIJAS (LOSARTÁN/HIDROCLOROTIAZIDA) vs MONOTERAPIA (ESTRATAAR).(STRATEGIES FOR THE TREATMENT OF ARTERIAL HYPERTENSION. ASSESSMENT OF A COMBINED THERAPY AT FIXED DOSES (LOSARTAN/HYDROCHOLOTHIAZIDE) vs MONOTHERAPY (ESTRATAAR)

Ongoing
4
140
Europe
COZAAR PLUS (losartán / hydrochlorothiazide), COZAAR PLUS, COZAAR PLUS
Catalan Society of Family Medicine, represented by Dr Mariano de la Figuera Von Wichman and Gabriel
Stage II arterial Hypertension
 
 
2009-010280-17: TS HYPE - Turner syndrome and Hypertension; a double-blinded randomised interventional trial.

Ongoing
4
40
Europe
Cozaar, Carvedilol PCD, Cozaar, Carvedilol PCD
Organisation name was not entered
Turner syndrome, hypertension and aortopathy
 
 
2007-006059-37: ENSAYO CLÍNICO PILOTO, ALEATORIZADO, CONTROLADO, PARALELO, DOBLE-CIEGO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LOSARTÁN EN LA REDUCCIÓN DEL ESTRÉS OXIDATIVO Y LA DISMINUCIÓN DE LA TENSIÓN ARTERIAL (TA) EN PACIENTES CON SÍNDROME DE WILLIAMS (SW) Y DOS O MÁS COPIAS DEL GEN NCF1.

Ongoing
4
60
Europe
COZAAR 50 mg comprimidos recubierto con pelicula, COZAAR 50 mg comprimidos recubierto con pelicula
Programa de Medicina Molecular y Genética, Hospital Vall d´Hebron
Pacientes con síndrome de Williams con evidencia molecular de microdeleción en 7q11.2. Edad: Niños de más de 5 años y adultos Sexo: ambos sexos estarán representados lo más paritariemente posible Variante molecular de la deleción que confirme la presencia de 2 o más copias del gen NCF1.
 
 
2010-024175-58: Comparison of two treatment regimen of high blood pressure in patients with transplanted heart.

Ongoing
4
40
Europe
perindopril, losartan, furosemid, metoprolol, amlodipin, PRESTARIUM Neo, LORISTA 25, PRESTARIUM Neo Forte, LORISTA 50, LORISTA 100, PRESTARIUM Neo, LORISTA 25, PRESTARIUM Neo Forte, LORISTA 50, LORISTA 100
IKEM, IKEM
Compensation of arterial hypertension in heart transplant recipients. Renal function and its changes in heart transplant recipients.
 
 
2011-002995-17: Treatment trial of stiff skin syndrome with Losartan

Ongoing
4
1
Europe
Losartan,
Stiff skin syndrome
 
 
2014-002524-27: The PALM-study (Placebo, Losartan, Low sodium & Moxonidine after PE)

Ongoing
4
30
Europe
Losartankalium, Moxonidine, Losartankalium, Moxonidine
University Medical Center Utrecht, ZonMw
Post Partum Hypertension after preeclamptic pregnancy
 
 
2015-003542-68: Cognitive-behaviour therapy and losartan

Ongoing
4
40
Europe
losartan, N/A, Tablet
University of Oxford, MQ: Transforming Mental Health
DSM panic disorder, Panic disorder is a severe form of anxiety that is characterised by the occurence of intense panic attacks, without an apparent external reason., Psychiatry and Psychology [F] - Psychological processes [F02]
 
 
ChiCTR-IPR-16008108: Songling Xuemaikang Capsule for primary hypertension with the control of Losartan potassium: a multi-center, randomized, double-blind controlled trial

Recruiting
4
640
 
Songling Xuemaikang capsule,the placebo of Losartan Potassium ;Losartan Potassium, the placebo of Songling Xuemaikang capsule
Dongzhimen hospital affiliated of Beijing University of Chinese Medicine; Shanghai Changzheng hospital; Dongzhimen hospital affiliated of Beijing University of Chinese Medicine, Pharmaceutical Co., Ltd. Chengdu Nakasone
Primary hypertension
 
 
ChiCTR-IPR-16009366: Clinical trial for evaluation of the breviscapine affect to cytochrome P450 enzymes and transporter in healthy volunteers

Recruiting
4
18
 
40mg po tid of placebo for two week, on the 15th day a single dose of fexofenadine120mg or midazolam 7.5mg or losartan potassium 50mg is given to volunteers ;40mg po tid of breviscapine for two week, on the 15th day a single dose of fexofenadine120mg or midazolam 7.5mg or losartan potassium 50mg is given to volunteers
College of Pharmacy and Chemistry, Dali University; College of Pharmacy and Chemistry, Dali University, Nation Natural Science Foundation of China
Healthy
 
 
NCT05827484: The Effect of Combined Use of Anti-fibrotic Agent With Platelet Rich Plasma on Skeletal Muscle Healing After Acute Injuries

Completed
4
20
NA
Autologous platelets rich plasma, PRP, Autologous platelets rich plasma + oral LOSARTAN administration, PRP + LOSARTAN
Mostafa Hassanein, Msc
PRP, Losartan, Muscle Injury, Sport Injury
09/17
12/17
ChiCTR-IIR-17013487: A multicenter, double blind, double dummy, randomized controlled clinical study on the treatment of IgA nephropathy with Zhengqingfengtongning extantab

Recruiting
4
108
 
Zhengqing Fengtongning extantab ;Losartan Potassium Tablets ;Losartan Potassium Tablets + Zhengqing Fengtongning extantab
The Third Xiangya Hospital of Central South University; The Third Xiangya Hospital of Central South University, Major projects of Hunan provincial science and Technology Department、Hunan Zhengqing Pharmaceutical Group Co., Ltd.
IgA nephropathy
 
 
2020-001595-15: Measures to slow the progression of chronic kidney disease in patients with protein in the urine and elevated potassium in the blood Et videnskabeligt forsøg med personer med kronisk nyresvigt og protein i urinen

Not yet recruiting
4
140
Europe
Spironolactone, Losartan, Tablet, Oral powder in sachet, Coated tablet, Veltassa
Henrik Birn, Vifor Fresenius Medical Care Renal Pharma AG, Graduate School of Health Sciences, Aarhus University
Chronic kidney disease with albuminuria Kronisk nyresygdom med albuminuri, Chronic kidney disease with protein in the urine Kronisk nyresygdom med æggehvidestof i urinen, Not possible to specify
 
 
2019-003141-15: Renohemodynamic Effects of Combined empagliflOzin and LosARtan

Not yet recruiting
4
24
Europe
Empagliflozine, Losartan, Film-coated tablet, Jardiance, Cozaar
Amsterdam University Medical Center - location VU Medical Center, Boehringer Ingelheim
Diabetes Mellitus type 2, Diabetes, Diseases [C] - Hormonal diseases [C19]
 
 
ChiCTR1900021113: Diabetic Kidney Disease with Qi and Yin Deficiency, Blood Stasis Syndrome Treated by Keluoxin Capsule Combined with Losartan Potassium: a randomized, double blinding, placebo controlled, multicenter clinical study

Not yet recruiting
4
252
 
Keluoxin Capsule+Losartan Potassium ;Placebo of Keluoxin Capsule + Losartan Potassium
Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences; Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Self-raising
Diabetic Kidney Disease
 
 
ChiCTR1900023531: Efficacy and safety of Astragalus plus Notoginseng granule on type 2 diabetic nephropathy: the multi-centre randomized controlled trial

Not yet recruiting
4
100
 
losartan ;Astragalus plus Notoginseng granule combined losartan
Shanghai Sixth People's Hospital East; Shanghai Sixth People's Hospital East Campus, Shanghai municipal health and family planning commission
diabetic nephrology
 
 
NCT06718062: Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia

Completed
4
66
RoW
Aliskiren, Losartan
Hansung University
Hypertension,Essential, Hyperuricemia
05/24
10/24
ChiCTR2000039934: The role of oral losartan in the prevention of acute mountain sickness: a randomized controlled trial

Not yet recruiting
4
200
 
oral Roxadustat capsules 50mg, BIW ;Oral placebo capsules,the same dosage as Oral Roxadustat
Western Theater Air Force Hospital; Western Theater Air Force Hospital, Western Theater Air Force Hospital
Acute altitude illness
 
 
2021-001661-21: Feasibility of aggressively lowering urine albumin in individuals with kidney biopsy-proven diabetic kidney disease - A Pilot Study

Not yet recruiting
4
20
Europe
Tablet, Injection, Forxiga, Jardiance, Ozempic, Telmisartan, Losartan, hydrochlorthiazide, Spironolactone, Trental, Olumiant, Kerendia, Rybelsus
Herlev and Gentofte Hospital, Herlev and Gentofte Hospital
Diabetic Kidney Disease, Kidney Disease due to diabetes mellitus type 2, Diseases [C] - Hormonal diseases [C19]
 
 
SEAL-IT, NCT04191681: Safety and Efficacy of ARNI After LVAD ImplanT () Study

Recruiting
4
50
US
Sacubitril-Valsartan, Entresto, Usual care (standard-of-care) arm, Oral Vasodilator
The Cleveland Clinic
Stage D Heart Failure
03/22
12/22
ChiCTR2000036108: Study on the safety and feasibility of losartan targeted therapy for pulmonary vein stenosis

Not yet recruiting
4
160
 
oral losartan ;Not taking losartan
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine; Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai Shen Kang Hospital Development Center
Acquired pulmonary venous obstruction
 
 
MRA-ACE, NCT03502031: Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

Recruiting
4
72
US
Renin-Angiotensin (RAAS) alone, Lispril, Enalapril, Perindopril, Losarta, Valsar etc.,, Renin-Angiotensin (RAAS) blockers in combination with Spironolactone, Lisinopril, Enalapril, Perindopril, Losartan, Valsartan, or Spironolactone
James A. Tumlin, MD, Nelson Kopyt, MD
Renal Insufficiency, Chronic, Diabetic Nephropathy Type 2
10/22
10/24
ChiCTR2000040391: Efficacy, safety and weight loss mechanism of pegylated losartan in obese patients with type 2 diabetes mellitus

Not yet recruiting
4
150
 
placebo ;Losenatide 100ug ;Losenatide 200ug ;Losenatide 300ug ;orlistat
The Second XIANGYA Hospital Of Central South University; The Second XIANGYA Hospital Of Central South University, Supported by China International Medical Exchange Foundation, Sumei China Diabetes Research Foundation in 2020
obese patients with type 2 diabetes mellitus
 
 
NCT06431477: Efficacy and Safety of Telmisartan Compared With Losartan

Recruiting
4
98
RoW
telmisartan, Losartan
Chong Kun Dang Pharmaceutical
Diabetic Nephropathies, Hypertension
10/25
10/25
NCT03692013: Nighttime Losartan in Continous Ambulatory Peritoneal Dialysis (NVCAPD)

Not yet recruiting
4
68
NA
Losartan, Cozaar
Fifth Affiliated Hospital, Sun Yat-Sen University, Third Affiliated Hospital, Sun Yat-Sen University
Hypertension,Nephropathy
06/23
12/23
ChiCTR2000035247: Clinical study of oral losartan application for the treatment of knee osteoarthritis: a randomized controlled trial.

Not yet recruiting
4
98
 
Oral losartan 50mg/ for 2 years ;Oral placebo 50mg/ for 2 years
Shenzhen Second People's Hospital; Shenzhen Second People's Hospital, Clinical Research Project of Shenzhen Second People's Hospital
osteoarthritis
 
 
WARRIOR, NCT03417388: Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD

Active, not recruiting
4
2476
US
High dose potent statin, atorvastatin or rosuvastatin, ACE-I (lisinopril) or ARB (losartan), ACE-I or ARB, Aspirin, Lifestyle Counseling, PACE Lifestyle Intervention, Quality of Life Questionnaires, QOL
University of Florida, United States Department of Defense
Coronary Artery Disease
02/25
09/25
ChiCTR2000029417: Astragali Radix and Panax notoginseng combination for the treatment of diabetic nephropathy: clinical randomized controlled trial and mechanism study

Recruiting
4
106
 
Placebo combined with losartan ;Astragalus plus Notoginseng granule combined losartan
Shanghai Sixth People's Hospital; Shanghai Sixth People's Hospital, National Key R&D Program of China
diabetic nephrology
 
 
NCT05402397: Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies

Recruiting
4
40
RoW
Losartan Potassium
Hospital General de Niños Pedro de Elizalde
Uric Acid Nephropathy
12/23
07/24
PRISTINE, NCT05843162: A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome

Not yet recruiting
4
116
NA
Telmisartan, Losartan
Chong Kun Dang Pharmaceutical
Essential Hypertension, Metabolic Syndrome
12/23
12/23
CLIgAN, NCT04662723 / 2021-006854-29: Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

Recruiting
4
878
Europe
Corticosteroid, Methylprednisolone succinate, prednisolone, Renin-angiotensin sytem blockers, Ramipril, lisinopril, losartan, Sodium-glucose cotransporter 2 inhibitor, dapagliflozin, canagliflozin, empagliflozin
Fondazione Schena, University of Bari
Glomerulonephritis, Immunoglobulin A Nephropathy
06/24
12/26
NCT06333522: Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

Withdrawn
4
240
US
Losartan
NYU Langone Health
Arthrofibrosis of Knee
01/26
01/26
NCT05157464: Losartan Use to Mitigate Arthrofibrosis Following Total Join Arthroplasty

Withdrawn
4
380
US
Losartan
NYU Langone Health
Arthrofibrosis
12/24
12/24
ChiCTR2300078226: Efficacy and safety of initial treatment of Finerenone combined with Henagliflozein in patients with type 2 diabetes with microalbuminuria: a randomized, parallel, controlled, three-arm clinical study

Recruiting
4
300
 
Losartan 50mg qd combined with Henagliflozein 5mg qd; Losartan 50mg qd combined with Finerenone 10mg qd; Losartan 50mg qd in combination with Finerenone 10mg qd and Henagliflozein 5mg qd
Peking University First Hospital; Peking University First Hospital, self-funded
Type 2 diabetes
 
 
NCT02817360: NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

Recruiting
4
2400
Europe, RoW
RAS-antagonist and beta-blocker up-to maximal dosages, Enalapril 40mg/d, Ramipril 10mg/d, Lisinopril 40mg/d, Cilazapril 5mg/d, Perindopril 8mg/d, Captopril 150mg/d, Spirapril 24mg/d, Quinapril 40mg/d, Trandolapril 4mg/d, Zofenopril 60mg/d, Fosinopril 40mg/d, Candesartan 32mg/d, Valsartan 320mg/d, Irbesartan 300mg/d, Losartan 150mg/d, Eprosartan 800mg/d, Bisoprolol 10mg/d, Metoprololsuccinat 200mg/d, Carvedilol 50mg/d (100mg/d if weight is > 85kg), Nebivolol 10mg/d, RAS-antagonist and beta-blocker none or at stable dose
Martin Huelsmann
Heart Diseases, Diabetes Mellitus, Type 2
12/25
12/26
NCT04715568: Secondhand Tobacco Smoke and Cardiovascular Disease

Recruiting
4
100
US
Losartan, Cozaar, Angiotensin II Receptor Blocker, Antihypertensive, Placebo, Inactive drug
University of California, San Francisco, Flight Attendant Medical Research Institute
Cardiovascular Diseases, Hypertension
12/25
12/25
2013-002091-41: Research into the effect of the drug losartan in adult patients with a reduced function of the right cardiac chamber and a cardiac birth defect Onderzoek naar de werking van het medicijn losartan bij volwassen patienten met een verminderde functie van de rechter hartkamer en een aangeboren hartafwijking

Ongoing
3/4
120
Europe
Losartan, Capsule, hard, Losartan
Academisch medisch centrum, ICIN
To study the effect of losartan in adult patients with Tetralogy of Fallot and right ventricular dysfunction, defined as right ventricular ejection fraction <50%. Without severe valvular lesions., Research into the effect of the drug losartan in patients with tetralogy of Fallot and decreased right heart chamber function, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2015-000239-34: A clinical study to investigate the use of commonly used heart failure medicines in the prevention of heart related illnesses in patients with diabetes mellitus but without heart disease.

Ongoing
3/4
2400
Europe, RoW
Enalapril maleate, Ramipril, Lisinopril dihydrate, Perindopril arginine, Perindopril erbumine, Perindopril tert-butylamine, Captopril, Quinapril hydrochloride, Trandolapril, Fosinopril sodium, Candesartan cilextil, Valsartan, Irbesartan, Losartan potassium, Eprosartan mesilate, Bisoprolol fumerate, Carvedilol, Nebivilol hydrochloride, Not applicable, Tablet, , Capsule
Medizinische Universität Wien, Medical University of Vienna, Medizinische Universität Wien,
Type 2 diabetes mellitus, Type 2 diabetes, Diseases [C] - Hormonal diseases [C19]
 
 
2005-004545-34: Can Angiotensin II type 1 Receptor Inhibitor Be Used to Lower the Amount of Lipase and Amylase Level after Endoscopic Retrograde Cholangio-Pancreatography?

Ongoing
3
400
Europe
Cozaar, Cozaar
Unit of Esophageal and Gastric Research Dep. of Molecular Medicine and Surgery Karolinska Institutet
The clinical diagnosis of acute pancreatitis is set by a combination of symptoms (abdominal pain) and increased blood levels of pancreatic enzymes (i.e. amylase and lipase). The most common complication of Endoscopic Retrograde Cholangio-Pancreatography (ERCP) is acute pancreatitis (7%, Freeman et al 1996). Increased blood levels of amylase and lipase is seen in 25-40% of cases after ERCP (Tsujino et al 2005).
 
 
ACTRN12615001322527: Effect of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients: a randomized controlled trial

Active, not recruiting
3
88
 
Universiti Sains Malaysia, Universit Sains Malaysia
hypertension in End stage renal disease
 
 
ChiCTR1800016427: A randomized, double-blind, double-simulation controlled trial of Sang-qi Granula on treating of vascular endothelial function of primary hypertension

Not yet recruiting
3
300
 
Traditional Chinese medicine group will be given San-qi Granula and Cozaar placebo for 2 months, Sang-Qi granule will be taken every morning and evening, 10g every time, and the Cozaar placebo will be taken 50mg every morning. ;Western medicine group will be given Cozaar and San-qi Granula placebo for 2 months, and Cozaar will be taken 50mg every morning, Sang-Qi granule placebo will be taken every morning and evening, 10g every time. ;Traditional Chinese medicine+ Western medicine group will be given San-qi Granula and Cozaar for 2 months, Sang-Qi granule will be taken every morning and evening, 10g every time, and the Cozaar will be taken 50mg every morning.
China-Japanese Friendship Hospital; China-Japanese Friendship Hospital, Funding for scientific research on capital health development in 2018, The State Administration of traditional Chinese medicine
primary hypertension
 
 
ARBs CORONA II, NCT04606563: Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?

Terminated
3
341
Europe, Canada
Losartan, Cozaar, Valsartan, Diovan, Azilsartan, Edarbi, Candesartan, Atacand, Eprosartan, Teventen, Irbesartan, Avapro, Olmesartan, Olmetec, Telmisartan, Micardis
University of British Columbia, Canadian Institutes of Health Research (CIHR)
Covid19, SARS-CoV Infection
04/22
04/22
TREAT-SVDs, NCT03082014 / 2016-002920-10: Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function

Terminated
3
101
Europe
Amlodipine, Losartan, Atenolol
Ludwig-Maximilians - University of Munich, University of Edinburgh, Maastricht University Medical Center, UMC Utrecht, University of Oxford
Cerebral Small Vessel Diseases
07/22
07/22
ChiCTR1800014345: The preventive effect of improving high filtration in subclinical stage on diabetic nephropathy: a prospective, multicenter cohort study

Recruiting
3
120
 
dapagliflozin ;Losartan ;Empagliflozin
Tianjin Metabolic Diseases Hospital & Tianjin Medical University; Tianjin Medical University Metabolic Diseases Hospital, Tianjin Medical University
diabetic nephropathy
 
 
2022-001682-12: A study to assess the efficacy of a cardiac drug and a anti-inflammatory drug in patients with post-acute inflammatory heart disease due to COVID-19

Not yet recruiting
3
280
Europe
Losartan-Kalium, Prednisolon 10 mg, Prednisolon, Capsule, hard, Losartan-Kalium TAD® 12,5 mg Filmtabletten, Losartan-Kalium TAD® 25 mg Filmtabletten, Prednisolon 10 mg JENAPHARM®, Prednisolon 5 mg JENAPHARM®
Goethe University Frankfurt, Bayer AG
Inflammatory cardiovascular involvement due to COVID-19, defined by Cardiovascular magnetic resonance imaging, COVID-19 disease with cardiovascular inflammatory involvement, Diseases [C] - Virus Diseases [C02]
 
 
NCT04591210: The COVID-RASi Trial (COVID-19)

Active, not recruiting
3
1155
Canada, RoW
Angiotensin converting enzyme inhibitor, Angiotensin II Receptor Blockers
Ottawa Heart Institute Research Corporation
COVID-19, Cardiovascular Diseases
12/24
12/25
VALUE, NCT06150560: A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling ( Trial)

Recruiting
3
120
US
Losartan, Cozaar, Amlodipine, Placebo
Mayo Clinic, National Heart, Lung, and Blood Institute (NHLBI)
Coarctation of Aorta, High Blood Pressure
06/28
06/28
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
REMAP-CAP, NCT02735707 / 2015-002340-14: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Recruiting
3
20000
Europe, Canada, Japan, US, RoW
Ceftriaxone, Moxifloxacin or Levofloxacin, Piperacillin-tazobactam, Ceftaroline, Amoxicillin-clavulanate, Standard course macrolide, Extended course macrolide, No systemic corticosteroid, Fixed-duration Hydrocortisone, Shock-dependent hydrocortisone, Fixed-duration higher dose Hydrocortisone, No antiviral agent for influenza, Five-days oseltamivir, Ten-days oseltamivir, No antiviral agent for COVID-19, Lopinavir / Ritonavir, Hydroxychloroquine, Hydroxychloroquine + lopinavir/ritonavir, Ivermectin, No immune modulation for COVID-19, Interferon beta-1a, IFN-β1a, Anakinra, Tocilizumab, Sarilumab, Local standard venous thromboprophylaxis, Therapeutic dose anticoagulation, Conventional low dose thromboprophylaxis, Intermediate dose thromboprophylaxis, Continuation of therapeutic dose anticoagulation, No immunoglobulin, Convalescent plasma, Delayed administration of convalescent plasma, No vitamin C, Vitamin C, No antiplatelet, Aspirin, acetylsalicylic acid, P2Y12 inhibitor, Clopidogrel, Prasugrel, Ticagrelor, No simvastatin, Simvastatin, Eritoran, Apremilast, Clinician-preferred mechanical ventilation strategy, Protocolised mechanical ventilation strategy, No renin-angiotensin system inhibitor, Angiotensin converting enzyme inhibitor, Ramipril, Lisinopril, Perindopril, Enalapril, Trandolapril, Captopril, Angiotensin Receptor Blockers, Losartan, Valsartan, Candesartan, Irbesartan, Telmisartan, Olmesartan, ARB + DMX-200, No cysteamine, Cysteamine, Fixed-duration dexamethasone, Baloxavir Marboxil, Five-days oseltamivir + baloxavir marboxil, Ten-days oseltamivir + baloxavir marboxil, No endothelial modulator, Imatinib, No Immune Modulator for Influenza, Baricitinib, Nirmatrelvir/ritonavir, Paxlovid, Remdesivir, Nirmatrelvir/ritonavir + remdesivir
UMC Utrecht, Australian and New Zealand Intensive Care Research Centre, Medical Research Institute of New Zealand, Unity Health, Berry Consultants, Global Coalition for Adaptive Research, University of Pittsburgh Medical Center, Intensive Care National Audit & Research Centre, St. Marianna University School of Medicine, Nat Intensive Care Surveillance - MORU, National University Hospital, Singapore
Community-acquired Pneumonia, Influenza, COVID-19
02/26
02/28
NCT00720044: Effect of Losartan on Chronic Obstructive Pulmonary Disease (COPD)

Recruiting
2/3
120
US
Losartan, Cozaar, Placebo, "sugar pill"
National Heart, Lung, and Blood Institute (NHLBI)
COPD, Emphysema, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
06/12
09/12
ChiCTR-TRC-10000884: A Multiple-dose, Positive Controlled Phase II Trial of Allisartan

Completed
2
288
 
Allisartan 80mg, orally taken once daily for 8 weeks ;Allisartan 160mg, orally taken once daily for 8 week ;Allisartan 240mg, orally taken once daily for 8 weeks ;losartan 50mg, orally taken once daily for 8 weeks
Peking University People's Hospital; Shanghai Allist Pharmaceuticals, Shanghai Allist Pharmaceuticals, Inc.
Mild to moderate essential hypertension
 
 
2010-022073-34: Effetto antipertensivo di differenti dosi del Rostafuroxin inconfronto con Losartan, valutato con Rilevazioni Pressorie Ambulatoriali eMonitoraggio Pressorio nelle 24 ore in pazienti ipertesi portatori di unospecifico profilo genetico. Effetto antipertensivo di differenti dosi del Rostafuroxin inconfronto con Losartan, valutato con Rilevazioni Pressorie Ambulatoriali eMonitoraggio Pressorio nelle 24 ore in pazienti ipertesi portatori di unospecifico profilo genetico.

Not yet recruiting
2
280
Europe
Rostafuroxin, Losaprex 50 mg, PST2238, Losartan 50 mg, Capsule, hard, Tablet, Losaprex 50 mg cpr riv
CVIE THERAPEUTICS COMPANY LIMITED, Cvie Therapeutics Company Limited
Patients with arterial hypertension, bearers of a specific genetic profile (Presence of at least one mutated genotype or combination of genotypes corresponding to the list provided in Genetic Profile 1). Pazienti Italiani e Cinesi, con ipertensione arteriosa, mai trattati prima, portatori di un profilo genetico specifico, Hypertension Ipertensione, Diseases [C] - Cardiovascular Diseases [C14]
 
 
2009-016139-36: The AT1 receptor antagonist losartan for the prevention of excessive aortic root dilatation in children and adolescents with Marfan syndrom

Ongoing
2
25
Europe
Losartan, LOSARTAN \"Hexal\" 50 mg - Filmtabletten, LOSARTAN \"Hexal\" 50 mg - Filmtabletten
Medizinische Universität Wien, Univ.Klinik für Kinder-und Jugendheilkunde
Marfan-Syndrom
 
 
2010-018880-41: EFFECTS OF LOSARTAN ON AORTIC ROOT AND ASCENDING AORTA REMODELING IN PATIENTS WITH BICUSPID AORTIC VALVE.

Ongoing
2
40
Europe
LORTAAN, LORTAAN
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
PATIENTS WITH BICUSPID AORTIC VALVE.
 
 
2018-004653-24: Importance of ARB medication in preventing valvular heart disease Betydning af angiotensin receptor blocker behandling hos patienter med hovedpulsreklap forsnvring

Not yet recruiting
2
280
Europe
losartan, C09CA01, Tablet, losartan
Odense Universitets Hospital, Odense Universitetshospital
Aortic valve stenosis Aortastenose, Aortic valve narrowing Hovedpulsåreklapforsnævring, Diseases [C] - Cardiovascular Diseases [C14]
 
 
ACTRN12619001078145: Novel treatment of patients with Advanced Cancers using a combination of commonly available, low cost oral medications.

Terminated
2
50
 
Gillies McIndoe Research Institute, Gillies McIndoe Research Institute
Glioblastoma,, Metastatic Melanoma, Oral cavity Squamous cell carcinoma, Head and Neck skin Squamous cell carcinoma
 
 
NCT03563248: Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer

Active, not recruiting
2
168
US
FOLFIRINOX, Losartan, Nivolumab, SBRT, Surgery
Massachusetts General Hospital, Bristol-Myers Squibb, Stand Up To Cancer, Lustgarten Foundation
Pancreatic Cancer
07/22
06/27
COVIDANCE, NCT04643691: Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS

Terminated
2
78
Europe
Losartan 50 mg and Spironolactone 25 mg pillules oral use
Assistance Publique Hopitaux De Marseille
COVID-19, ARDS
12/21
12/21
2022-001939-88: Clinical study on the combination of Losartan (antihypertensive drug) and chemotherapy followed by stereotactic radiotherapy, a non-invasive radiotherapy technique, for the treatment of locally advanced pancreatic cancer Studio clinico sulla combinazione di Losartan (farmaco antipertensivo) e chemioterapia seguito da radioterapia stereotassica, tecnica radioterapica non invasiva, per il trattamento del Tumore del Pancreas Localmente Avanzato

Not yet recruiting
2
34
Europe
Losartan DOC 12,5 mg, LORTAAN, [Losartan DOC 12, 5 mg], [LORTAAN], Film-coated tablet, LOSARTAN DOC GENERICI - 12.5 MG COMPRESSE RIVESTITE CON FILM 21 COMPRESSE IN BLISTER PVC/PVDC/PELLICOLA DI ALLUMINIO, LORTAAN - 50 MG COMPRESSE RIVESTITE CON FILM 28 COMPRESSE
ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (IRST) S.R.L. IRCCS
Unresectable locally advanced, non-metastatic pancreatic cancer (as described by NCCN guidelines version 1.2022) Tumore del pancreas localmente avanzato non resecabile (come da linee guida NCCN versione 1.2022), Locally advanced non-metastatic and non-operable pancreatic cancer Tumore del pancreas localmente avanzato non metastatico e non operabile, Diseases [C] - Cancer [C04]
 
 
NCT03632213: Evaluation of Losartan on Cardiovascular Disease in Patients With Mucopolysaccharidoses IV A and VI

Active, not recruiting
2
10
RoW
Losartan, Placebo
Hospital de Clinicas de Porto Alegre, The Isaac Foundation
Mucopolysaccharidosis IV A, Mucopolysaccharidosis VI, Mucopolysaccharidoses, MPS IV A, MPS VI, MPS - Mucopolysaccharidosis, Morquio A Syndrome, Morquio Syndrome A, Morquio Syndrome
05/23
08/23
REVERSE-AR, NCT05212597: Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB

Recruiting
2
100
RoW
Sacubitril-valsartan, Entresto, Amlodipine-losartan, Amosartan
Samsung Medical Center
Aortic Valve Insufficiency
12/23
12/24
NCT06135493: Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients

Recruiting
2
84
RoW
Losartan
Future University in Egypt
Peripheral Neuropathy Due to Chemotherapy
03/25
03/25
NCT05012631: Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Recruiting
2
24
US
Losartan
Children's Hospital Medical Center, Cincinnati
Sickle Cell Disease, Diffuse Myocardial Fibrosis
12/25
12/26
NCT05077800: FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer

Recruiting
2
70
US
FOLFIRNINOX, Losartan, Cozaar, 9-ING-41
Colin D. Weekes, M.D., PhD, Actuate Therapeutics Inc., Lustgarten Foundation
Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
12/25
07/26
NeoOPTIMIZE, NCT04539808: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer

Active, not recruiting
2
60
US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5 Fluorouracil, 5 Fluorouracilum, 5 FU, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-Fu, 5FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Irinotecan Hydrochloride, Campto, Camptosar, Camptothecin 11, Camptothecin-11, CPT 11, CPT-11, Irinomedac, Irinotecan Hydrochloride Trihydrate, Irinotecan Monohydrochloride Trihydrate, U-101440E, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, Citrovorum Factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Losartan Potassium, Cozaar, losartan, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Resection, Surgical Resection, Diagnostic Imaging, Medical Imaging, Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection
OHSU Knight Cancer Institute, Oregon Health and Science University
Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8, Stage I Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8
04/25
10/25
HIPAC, NCT03354143: Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults ( Trial)

Completed
2
85
US
Standard Care, Intensive Treatment
University of Texas Southwestern Medical Center, Texas Health Resources, Michigan State University
Hypertension
01/24
03/24
ACES, NCT03295734: - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

Completed
2
223
US
Aerobic exercise, Perindopril, Losartan, HCTZ
University of Alabama at Birmingham, University of Colorado, Denver, AdventHealth Translational Research Institute
Hypertension, Aging, Sedentary Lifestyle
09/24
09/24
NCT05871333: Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Recruiting
2
80
RoW
Losartan 50mg Tab, Angiotension receptor blockers
Ain Shams University
Chemotherapy, Colorectal Cancer, Intestinal Mucositis, Oral Mucositis
06/24
07/24
NCT06364176: Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.

Recruiting
2
42
US
Losartan, Placebo
University of Kansas Medical Center
Cystic Fibrosis
05/27
10/27
ChiCTR2200064190: Exploring the Optimal Diagnosis and Treatment Strategy of Traditional Chinese Medicine Preparation Sangqi Qingxuan Ointment For Prevention and Treatment of Prehypertension and Grade 1 Hypertension: Based on the Regulation of Autonomic Nerve Function

Not yet recruiting
2
180
 
Sangqi Qingxuan Ointment ;Losartan Potassium
China-Japan Friendship Hospital; China-Japan Friendship Hospital, China-Japan Friendship Hospital
hypertension
 
 
ImPRESS, NCT03951142 / 2018-003229-27: Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study

Enrolling by invitation
2
165
Europe
Losartan
Kyrre Eeg Emblem
Glioblastoma, Brain Metastases
10/24
12/24
WHUH-BC-001, NCT05097248: Camrelizumab in Combination With PLD and Losartan in Patients With TNBC Who Have Received ≦ 1 Line of Chemotherapy

Not yet recruiting
2
52
RoW
Camrelizumab, Liposomal Doxorubicin, Losartan
Wuhan Union Hospital, China, Jiangsu HengRui Medicine Co., Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Breast Cancer
10/24
10/24
NCT05370599: Hypertension in Young Adults Trial

Recruiting
2
120
US
Anti-hypertensive agent: amlodipine, Anti-hypertensive agent: Chlorthalidone, Anti-hypertensive agent: Losartan, Home BP monitoring with cuffed device, Home BP monitoring with cuffed device + BP patch, Home BP monitoring with cuffed device + BP watch
University of California, San Francisco
Hypertension
05/25
05/27
ChiCTR2400082666: A single-arm, multicenter prospective study of RAS inhibitors combined with bevacizumab in patients with mCRC

Recruiting
2
92
 
losartan+Bevacizumab + chemotherapy (CapeOx+mXELIRI)
Jiangjin Central Hospital of Chongqing; Jiangjin Central Hospital of Chongqing, Scientific research fund
colorectal cancer
 
 
OVERPASS, NCT05861336 / 2022-001939-88: GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer

Withdrawn
2
34
Europe
Losartan, Gemcitabine, Nab paclitaxel, Stereotactic Body Radiation Therapy
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
Pancreatic Cancer
12/24
12/24
NCT01199978: Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Active, not recruiting
2
30
US
Fractionated proton radiation, Losartan, Cozaar
Massachusetts General Hospital, National Cancer Institute (NCI)
Vestibular Schwannoma, Acoustic Neuroma
11/26
11/26
IPAT, NCT05331144: Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau ( Study)

Recruiting
2
180
US
Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine), PCP
Rong Zhang, National Institute on Aging (NIA), Texas Health Resources, Michigan State University
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline, Family History of Dementia
06/27
12/27
NCT05637216: Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Recruiting
2
40
NA
Losartan 25 milligram capsule, losartan potassium, Placebo
Shaw Cancer Center, Steadman Philippon Research Institute
Radiation Induced Fibrosis
08/27
08/27
NCT02263729: Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains

Terminated
1/2
8
US
Losartan, Placebo
James J. Irrgang, Brooke Army Medical Center, Wake Forest University
Hamstring Injury
12/22
12/22
PolyPreventHF, NCT06143566: Polypill for Prevention of Cardiomyopathy

Recruiting
1/2
60
US
Polypill, (Finerenone, Empagliflozin, Losartan)
University of Texas Southwestern Medical Center
Type 2 Diabetes, High Blood Pressure
09/25
12/25
NCT05893108: Ethosomal Gel Bearing Losartan 5% for Keloid Treatment

Not yet recruiting
1/2
46
RoW
Ethosomal gel bearing losartan 5%, triamcinolone acetonide 10 mg/ml, TA 10 mg/ml
Yuni Eka Anggraini, Gadjah Mada University
Keloid
09/24
10/24
NCT05025956: Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan

Active, not recruiting
1/2
68
US
Fisetin, Novusetin, 7,3',4'-flavon-3-ol, 3,3',4',7-tetrahydroxyflavone, Placebo, Placebo Oral Capsule
Steadman Philippon Research Institute, United States Department of Defense
Femoroacetabular Impingement
10/24
10/24
RMIP, NCT04815902: Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

Active, not recruiting
1/2
100
US
Fisetin, Novusetin, 7,3',4'-flavon-3-ol, 3,3',4',7-tetrahydroxyflavone, Losartan, Losartan potassium, Placebo - Losartan, Placebo Oral Capsule, Placebo Fisetin
Steadman Philippon Research Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Osteoarthritis, Knee
02/25
06/25
NCT06108063: Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

Recruiting
1/2
120
US
Losartan, Losartan potassium, Placebo - Losartan, Placebo Oral Tablet
Steadman Philippon Research Institute
Knee Arthroplasty, Total
06/27
06/27
ACTRN12620000731998p: Will treating the overwhelming patient response with medications affect COVID-19 mortality?

Not yet recruiting
1
36
 
NSW Health via the Hunter New England Local Health District
COVID-19
 
 
ACTRN12620000731998: Will treating the overwhelming patient response with medications affect COVID-19 mortality?

Not yet recruiting
1
36
 
NSW Health via the Hunter New England Local Health District
COVID-19
 
 
ChiCTR-TRC-10000885: A Positive Controlled Phase III Trial of Allisartan

Completed
1
720
 
losartan 50mg, orally taken once daily for 12 week ;Allisartan 240mg, orally taken once daily for 12 weeks
Peking University People's Hospital; Shanghai Allist Pharmaceuticals, Inc., Shanghai Allist Pharmaceuticals, Inc.
Mild to moderate essential hypertension
 
 
ChiCTR-TRC-10001518: Helping Ease Renal Failure with Bupiyishen (HERB) Trial: A Randomised Controlled Trial of Bupi Yishen for slowing kidney failure progression in stage 4 chronic kidney disease

Completed
1
550
 
BU PI YI SHEN Formula+placebo of Losartan+basal treatment ;Lorsartan+placebo of BU PI YI SHEN Formula+basal treatment
Guangdong Provicial Hospital of Chinese Medicine; State Bureau of Quality Technical Supervision of China, State Bureau of Quality Technical Supervision of China
chronic kidney disease 4th stage
 
 
ChiCTR1900027242: Pharmacokinetics study to compare Allisartan with Losartan

Not yet recruiting
1
16
 
phase I: Allisartan; phase II: Losartan ;phase I: Losartan; phase II: Allisartan.
The Third Xiangya Hospital of Central South University; Shenzhen Salubris Pharmaceuticals Co., Ltd., Sponsor
Hypertension
 
 
 

Download Options